tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EKF Diagnostics Buys Back Shares, Manages Major Shareholder’s Stake

Story Highlights
  • EKF Diagnostics repurchased 93,980 shares at 25.5p, holding them in treasury and trimming voting share count.
  • The buyback included 28,000 shares from Harwood-managed funds to keep director Christopher Mills’ stake below 30%.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EKF Diagnostics Buys Back Shares, Manages Major Shareholder’s Stake

Claim 70% Off TipRanks This Holiday Season

EKF Diagnostics Holdings ( (GB:EKF) ) has shared an update.

EKF Diagnostics Holdings has repurchased 93,980 of its ordinary shares at 25.5 pence each, holding the stock in treasury and reducing the number of shares in issue that carry voting rights to 435,148,112. The buyback included the purchase of 28,000 shares from funds managed by Harwood, structured to keep non-executive director Christopher Mills’ aggregate indirect stake at roughly the same level and below 30% of voting rights, a move that helps manage shareholder concentration while signalling continued capital management activity by the diagnostics group.

The most recent analyst rating on (GB:EKF) stock is a Hold with a £27.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.

Spark’s Take on GB:EKF Stock

According to Spark, TipRanks’ AI Analyst, GB:EKF is a Neutral.

EKF Diagnostics Holdings receives a score of 67, driven by strong financial performance and a positive earnings call. The company’s robust balance sheet and improved profitability are significant strengths. However, technical indicators suggest potential bearish momentum, and the valuation is moderate. The positive outlook from the earnings call, including strategic growth plans and a share buyback program, enhances the overall score.

To see Spark’s full report on GB:EKF stock, click here.

More about EKF Diagnostics Holdings

EKF Diagnostics Holdings is an AIM-listed global diagnostics business specialising in point-of-care analysers in haematology and diabetes, as well as life sciences services that manufacture specialist enzymes and custom products for diagnostic, food and industrial applications. Headquartered in Penarth near Cardiff, the company operates five manufacturing sites across the US and Germany and sells into more than 120 countries worldwide.

Average Trading Volume: 510,308

Technical Sentiment Signal: Strong Sell

Current Market Cap: £112.3M

For a thorough assessment of EKF stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1